Лечението трябва да продължи до намаляване на риска от VTE, обикновено поне пет до девет дни след операцията.
For patients with unstable angina or myocardial infarction, the recommended dose is 2.5 mg once daily by subcutaneous injection, but the first dose is given intravenously (into a vein) through an existing line or as an infusion (drip) in patients with ST segment elevation.